Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 0 | 817 | 779 | 913 | 650 |
| Operating Income | N/A | -817 | -779 | -913 | -650 |
| Interest Expense | 0 | 2,443 | -111 | 77 | 2 |
| Other Income | 0 | 2 | 56 | 370 | -34 |
| Pre-tax Income | 0 | -3,258 | -613 | -620 | -686 |
| Net Income Continuous | N/A | -3,258 | -613 | -620 | -686 |
| Net Income | $N/A | $-3,258 | $-613 | $-620 | $-686 |
| EPS Basic Total Ops | N/A | -80.00 | -25.96 | -21.04 | -21.00 |
| EPS Basic Continuous Ops | N/A | -80.21 | -18.14 | -18.35 | -20.31 |
| EPS Diluted Total Ops | N/A | -80.00 | -25.96 | -21.04 | -21.00 |
| EPS Diluted Continuous Ops | N/A | -80.21 | -18.14 | -18.35 | -20.31 |
| EBITDA(a) | $N/A | $-776 | $-741 | $-870 | $-610 |